LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework

21/09/2022
PRESS RELEASE

Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework

Brussels, 21 September 2022 – EuropaBio is pleased to announce that Freget Glaser & Associés has joined as an associate member. A law firm based in Paris, focusing on EU competition, regulatory and public economic law, Fréget Glaser has been advising pharmaceutical and innovative companies for more than 20 years.

Adding to their legal expertise a deep knowledge of the regulated sectors, the firm supports its clients in the definition and implementation of their legal strategy and represents them before the French courts, competition and sector regulatory authorities, as well as before the European Commission and Court of Justice.

EuropaBio Director-General Dr. Claire Skentelbery commented “We are thrilled to have a law firm among our members, and we are confident that Freget Glaser’s expertise in legal and regulatory strategy can bring an added value to the association”.

Olivier Fréget, Founding Partner of Freget Glaser & Associés, added: “We have seen the life sciences sector evolve around the major technological and scientific developments, particularly in biotech. These have raised numerous regulatory challenges that continue to stimulate the debate. We look forward to contributing to these thought exchanges from our legal perspective”.

Freget Glaser & Associés joins EuropaBio


Download
2022_09_G_PR_Freget-Glaser-joins-EuropaBioDownload
Share
Communications Team
Communications Team

Related posts

31/10/2025

Healthcare Associations warn of risks from PFAS restriction approach  – failure to assess the impact on the availability of human and animal medicines


Read more
14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more

Important links

  • Healthcare Associations warn of risks from PFAS restriction approach  – failure to assess the impact on the availability of human and animal medicines
  • Public Consultation Response to the European Innovation Act proposal

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.